Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00315328 · ClinicalTrials.gov registry record · Phase 3
Trial Comparing Patching Versus Atropine for Amblyopia in 7 to < 13 Year Olds
A Phase 3 study, sponsored by Jaeb Center for Health Research.
- Completed
- Registry status
- Phase 3
- Development phase
- 233
- Enrollment target
NCT00315328 is a Phase 3 study that has completed, run by Jaeb Center for Health Research. The registered enrollment target is 233 participants.
The verdict
NCT00315328, a Phase 3 study, has completed, sponsored by Jaeb Center for Health Research.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 233 participants
- Enrollment target
Study Summary
The purpose of this study is: * To compare the effectiveness of weekend atropine plus near activities and daily patching plus near activities for moderate amblyopia (20/40 to 20/100) and severe amblyopia (20/125 to 20/400) in improving vision in the amblyopic eye of 7 to \<13 year olds. * To determine the maximum improvement in vision of the amblyopic eye with each treatment. * To determine whether amblyopia is associated with structural abnormalities of optic nerve fiber layer.
Interventions
- DRUG Atropine
- DEVICE Patching
- PROCEDURE Near activities
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 233 participants |
| Start Date | 2005-08 |
| Est. Completion | 2008-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00315328
The ClinicalTrials.gov registry entry for NCT00315328 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 233 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Jaeb Center for Health Research, which has 119 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Atropine is the first listed.
NCT00315328 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00315328 about?
NCT00315328 is a clinical study titled "Trial Comparing Patching Versus Atropine for Amblyopia in 7 to < 13 Year Olds". The purpose of this study is: * To compare the effectiveness of weekend atropine plus near activities and daily patching plus near activities for moderate amblyopia (20/40 to 20/100) and severe amblyopia (20/125 to 20/400) in improving vision in the amblyopic eye of 7 to \<13 year olds. * To determ...
What is the current status of trial NCT00315328?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 233 participants. The study started on 2005-08. Estimated completion is 2008-01.
What interventions are being tested in trial NCT00315328?
The interventions under investigation include: Atropine (DRUG), Patching (DEVICE), Near activities (PROCEDURE).
Who is sponsoring clinical trial NCT00315328?
This trial is sponsored by Jaeb Center for Health Research, which has 119 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.